88 related articles for article (PubMed ID: 8698274)
1. Thrombin-antithrombin III complexes as an additional diagnostic aid in pulmonary embolism.
Carmassi F; Morale M; de Negri F; Puccetti R; Pistelli F; Mariani G; Pazzagli M; Palla A; Giuntini C
Haemostasis; 1996; 26(1):16-22. PubMed ID: 8698274
[TBL] [Abstract][Full Text] [Related]
2. Clinical, anamnestic and coagulation data in patients with suspected or confirmed pulmonary embolism.
Palla A; Pazzagli M; Manganelli D; Carmassi F; Giuntini C
Respiration; 1994; 61(2):93-8. PubMed ID: 8008995
[TBL] [Abstract][Full Text] [Related]
3. D-dimer and thrombin-antithrombin III complexes in patients with clinically suspected pulmonary embolism.
Demers C; Ginsberg JS; Johnston M; Brill-Edwards P; Panju A
Thromb Haemost; 1992 Apr; 67(4):408-12. PubMed ID: 1631787
[TBL] [Abstract][Full Text] [Related]
4. Coagulation and fibrinolytic system impairment in insulin dependent diabetes mellitus.
Carmassi F; Morale M; Puccetti R; De Negri F; Monzani F; Navalesi R; Mariani G
Thromb Res; 1992 Sep; 67(6):643-54. PubMed ID: 1440530
[TBL] [Abstract][Full Text] [Related]
5. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis.
Yamada N; Wada H; Nakase T; Minamikawa K; Nagaya S; Nakamura M; Hiraoka N; Fuzioka H; Hayashi T; Suzuki K
Blood Coagul Fibrinolysis; 1995 Oct; 6(7):627-33. PubMed ID: 8562833
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary embolism. Efficacy of D-dimer and thrombin-antithrombin III complex determinations as screening tests before lung scanning.
Leitha T; Speiser W; Dudczak R
Chest; 1991 Dec; 100(6):1536-41. PubMed ID: 1959391
[TBL] [Abstract][Full Text] [Related]
7. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
8. Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.
Raaphorst J; Johan Groeneveld AB; Bossink AW; Erik Hack C
Thromb Haemost; 2001 Aug; 86(2):543-9. PubMed ID: 11522001
[TBL] [Abstract][Full Text] [Related]
9. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication.
Handa K; Takao M; Nomoto J; Oku K; Shirai K; Saku K; Arakawa K
Angiology; 1996 Jun; 47(6):543-8. PubMed ID: 8678328
[TBL] [Abstract][Full Text] [Related]
11. Use of enzyme-linked immunosorbent assay to measure thrombin-antithrombin III complexes in horses with colic.
Topper MJ; Prasse KW
Am J Vet Res; 1996 Apr; 57(4):456-62. PubMed ID: 8712506
[TBL] [Abstract][Full Text] [Related]
12. Increased activated protein C-protein C inhibitor complex levels in patients with pulmonary embolism.
Minamikawa K; Wada H; Wakita Y; Ohiwa M; Tanigawa M; Deguchi K; Hiraoka N; Huzioka H; Nishioka J; Hayashi T
Thromb Haemost; 1994 Feb; 71(2):192-4. PubMed ID: 7514816
[TBL] [Abstract][Full Text] [Related]
13. Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly.
Sartorio A; Cattaneo M; Bucciarelli P; Bottasso B; Porretti S; Epaminonda P; Faglia G; Arosio M
Exp Clin Endocrinol Diabetes; 2000; 108(7):486-92. PubMed ID: 11083070
[TBL] [Abstract][Full Text] [Related]
14. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
15. Laboratory diagnosis of pulmonary embolism: value of increased levels of plasma D-dimer and thrombin--antithrombin III complexes.
Bounameaux H; Slosman D; de Moerloose P; Reber G
Biomed Pharmacother; 1989; 43(5):385-8. PubMed ID: 2676005
[TBL] [Abstract][Full Text] [Related]
16. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
[TBL] [Abstract][Full Text] [Related]
17. Application of thrombin-antithrombin III complex for detecting a latent hypercoagulable state in patients with coronary artery disease.
Uno M; Tsuji H; Watanabe M; Takada O; Kobayashi K; Takabuchi H; Shirai K; Sawada S; Toyoda T; Yamamoto K
Jpn Circ J; 1989 Oct; 53(10):1185-91. PubMed ID: 2693750
[TBL] [Abstract][Full Text] [Related]
18. Low prevalence of coagulation and fibrinolytic activation in patients with primary untreated cancer.
Nanninga PB; van Teunenbroek A; Veenhof CH; Büller HR; ten Cate JW
Thromb Haemost; 1990 Nov; 64(3):361-4. PubMed ID: 1710832
[TBL] [Abstract][Full Text] [Related]
19. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
[TBL] [Abstract][Full Text] [Related]
20. Do coagulation screening tests detect increased generation of thrombin and plasmin in sick newborn infants?
Schmidt B; Vegh P; Johnston M; Andrew M; Weitz J
Thromb Haemost; 1993 May; 69(5):418-21. PubMed ID: 8322263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
